![The sights of Paris Air Show Day 1 [PHOTOS]](https://breakingdefense.com/wp-content/uploads/sites/3/2025/06/IMG_1798-scaled-e1750092780492.jpg?#)
Sarepta reports 2nd death after DMD gene therapy Elevidys, stops dosing in half of patients
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy gene therapy’s safety profile.
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy gene therapy’s safety profile.
